Kalxone TZ 1000mg/125mg Injection
Marketer
Kalmia Healthcare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Kalxone TZ 1000mg/125mg Injection
Combiflox TZ, a 1000mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be solely under a physician's guidance; adherence to the prescribed schedule is crucial. Complete the full treatment course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms warrant immediate medical attention. Seek immediate medical care for allergic reactions (e.g., skin rashes, itching, edema, dyspnea). Disclose all current medications to your doctor before initiating treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Kalxone TZ 1000mg/125mg Injection
The provided text is "undefined," which lacks any content to rephrase. Therefore, no rewritten text can be provided.
Uses of Kalxone TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Kalxone TZ 1000mg/125mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Kalxone TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kalxone TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kalxone TZ 1000mg/125mg Injection works:
Ceftriaxone and Tazobactum, combined as Kalxone TZ 1000mg/125mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, compromising their viability. Tazobactum's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Kalxone TZ 1000mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Kalxone TZ (1000mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Kalxone TZ 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Kalxone TZ 1000mg/125mg Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kalxone TZ 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The administration of Kalxone TZ 1000mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification of Kalxone TZ 1000mg/125mg Injection might be necessary; physician consultation is advised. Altering the Kalxone TZ 1000mg/125mg Injection dose is generally not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Kalxone TZ 1000mg/125mg Injection :
Should you inadvertently omit a dose of Kalxone TZ 1000mg/125mg Injection, seek immediate medical advice.
Facts to Know About Kalxone TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective medications |
3,018 People bought this recently